K-numberK242624
Device nameMedical Image Post-processing Software (uOmnispace.CT)
ApplicantShanghai United Imaging Healthcare Co., Ltd.
Product codeQIH
Device classClass II
Decision dateMay 14, 2025
DecisionSubstantially Equivalent
Regulation892.2050
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

uOmnispace.CT is post-processing software for viewing, manipulating, evaluating, and analyzing medical images, primarily CT scans. It contains 15 applications for specialized analysis including lung density, vessel analysis, cardiac imaging, liver evaluation, brain perfusion, and body perfusion, supporting interpretation and clinical decision-making in healthcare institutions.

Technological characteristics

The proposed device introduces deep-learning algorithms for segmentation and extraction tasks (lung, airway, bone removal, coronary artery, heart chamber, liver, and hepatic vessels) and integrates both rigid and non-rigid motion correction. These enhancements provide improved automation while maintaining the same fundamental post-processing and visualization framework as the predicate device.

Test standards cited

NEMA PS 3.1–3.20 (DICOM), ISO 14971 (risk management), and IEC 62304 (software life cycle processes). Software verification and validation included hazard analysis, requirements specification, architecture design, and cybersecurity documentation. ML/AI algorithms were validated using Dice similarity coefficient against ground truth annotations across diverse patient populations.

Substantial equivalence argument

The proposed device performs substantially the same intended functions as the predicate (K233209) with identical classification, regulatory status, and clinical use. Although deep-learning algorithms enhance automation and motion correction methods improve accuracy, these represent iterative algorithmic improvements that do not alter the fundamental post-processing technology or clinical purpose. Performance testing demonstrates the algorithms meet or exceed acceptance criteria across diverse patient subgroups, maintaining safety and effectiveness equivalent to the predicate device.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →